SHS Capital is a leading German healthcare-dedicated private equity and growth capital firm based in Tübingen, founded in 1993. It invests in fast-growing healthcare companies across MedTech, Life Sciences, Diagnostics, and Digital Health, supporting them to become European healthcare champions.
100% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-a (60% of deals).
Portfolio
3
Fund Size
$292M
Top Stage
Series A
Last 12 Mo
0
Team
Marie Dechenoix
Investment Manager
Portfolio Breakdown
Stage Distribution
Investment Activity
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Salvia BioElectronics | Series B | $60M | May 2025 |
 Neuro Event Labs Oy | Series A | — | Feb 2025 |
| Neuro Event Labs Oy | Series A | — | Apr 2020 |
| Neuro Event Labs Oy | Series A | — | — |
 Pathoquest | Series B | — | — |
Top Co-Investors
Maki.vc3 shared
Hadean Ventures3 shared
SHS2 shared
European Commission1 shared
Eurazeo1 shared
Verve Ventures1 shared
Kurma Partners1 shared
Dolby Family Ventures1 shared
Sofinnova Partners1 shared
Thuja Capital1 shared
Invest-NL1 shared
OSS Capital1 shared
Innovation Industries1 shared
INKEF Capital1 shared
Business Finland1 shared
Last updated: 20 October 2026